| 1 |
35611209 | Circulating tumor DNA genomic profiling reveals the complicated olaparib-resistance mechanism in prostate cancer salvage therapy: A case report. | 2022 Apr 16 |
2 |
| 2 |
33308898 | Ongoing partial response at 6 months to olaparib for metastatic melanoma with somatic PALB2 mutation after failure of immunotherapy: a case report. | 2021 Feb |
1 |
| 3 |
33800556 | Germline Mutations in Other Homologous Recombination Repair-Related Genes Than BRCA1/2: Predictive or Prognostic Factors? | 2021 Mar 28 |
1 |
| 4 |
32728620 | Olaparib for metastatic breast cancer in a patient with a germline PALB2 variant. | 2020 |
2 |
| 5 |
30833416 | Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance. | 2019 Apr |
1 |
| 6 |
28450425 | Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition. | 2017 Sep |
1 |